Natera to Report its Second Quarter 2024 Results on August 8, 2024
Natera (NASDAQ: NTRA), a leader in cell-free DNA testing, has announced it will release its second quarter 2024 financial results on August 8, 2024, after market close. The company will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) on the same day to discuss the results.
Interested parties can access the conference call via the following dial-in numbers:
- Domestic: 1-888-596-4144
- International: 1-646-968-2525
- Conference ID: 7684785
A webcast of the call will be available at https://events.q4inc.com/attendee/455235752, with a replay accessible later at investor.natera.com.
Natera (NASDAQ: NTRA), un leader nei test del DNA circolante, ha annunciato che rilascerà i propri risultati finanziari del secondo trimestre 2024 il 8 agosto 2024, dopo la chiusura del mercato. L'azienda ospiterà una chiamata e una trasmissione in webcast alle 1:30 p.m. PT (4:30 p.m. ET) dello stesso giorno per discutere i risultati.
Le parti interessate possono accedere alla chiamata tramite i seguenti numeri:
- Domestico: 1-888-596-4144
- Internazionale: 1-646-968-2525
- ID Conferenza: 7684785
Una trasmissione in webcast della chiamata sarà disponibile su https://events.q4inc.com/attendee/455235752, con una registrazione accessibile successivamente su investor.natera.com.
Natera (NASDAQ: NTRA), un líder en pruebas de ADN sin células, ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 el 8 de agosto de 2024, después del cierre del mercado. La empresa llevará a cabo una llamada de conferencia y un webcast a las 1:30 p.m. PT (4:30 p.m. ET) del mismo día para discutir los resultados.
Las partes interesadas pueden acceder a la llamada de conferencia a través de los siguientes números:
- Doméstico: 1-888-596-4144
- Internacional: 1-646-968-2525
- ID de Conferencia: 7684785
Un webcast de la llamada estará disponible en https://events.q4inc.com/attendee/455235752, con una repetición accesible más tarde en investor.natera.com.
Natera (NASDAQ: NTRA)는 세포 외 DNA 검사 분야의 선두주자로서 2024년 2분기 재무 결과를 2024년 8월 8일, 시장 마감 후에 발표할 것이라고 발표했습니다. 회사는 같은 날 오후 1시 30분 PT (오후 4시 30분 ET)에 결과를 논의하기 위한 전화 회의 및 웹캐스트를 개최할 예정입니다.
관심 있는 분들은 다음의 다이얼인 번호를 통해 전화 회의에 접속할 수 있습니다:
- 국내: 1-888-596-4144
- 국제: 1-646-968-2525
- 회의 ID: 7684785
회의의 웹캐스트는 https://events.q4inc.com/attendee/455235752에서 이용할 수 있으며, 나중에 investor.natera.com에서 재생할 수 있습니다.
Natera (NASDAQ: NTRA), un leader dans le domaine des tests d'ADN libre, a annoncé qu'il publiera ses résultats financiers du deuxième trimestre 2024 le 8 août 2024, après la fermeture du marché. L'entreprise tiendra une conférence téléphonique et un webinaire le même jour à 13h30 PT (16h30 ET) pour discuter des résultats.
Les parties intéressées peuvent accéder à la conférence téléphonique via les numéros suivants :
- National : 1-888-596-4144
- International : 1-646-968-2525
- ID de la conférence : 7684785
Un webinaire de l'appel sera disponible sur https://events.q4inc.com/attendee/455235752, avec une rediffusion accessible ultérieurement sur investor.natera.com.
Natera (NASDAQ: NTRA), ein führendes Unternehmen im Bereich der zellfreien DNA-Tests, hat angekündigt, dass es seine Finanzergebnisse für das zweite Quartal 2024 am 8. August 2024, nach Handelsschluss veröffentlichen wird. Das Unternehmen wird am selben Tag um 13:30 Uhr PT (16:30 Uhr ET) eine Telefonkonferenz und einen Webcast veranstalten, um die Ergebnisse zu besprechen.
Interessierte Parteien können auf die Telefonkonferenz über die folgenden Durchwahlnummern zugreifen:
- Inland: 1-888-596-4144
- International: 1-646-968-2525
- Konferenz-ID: 7684785
Ein Webcast der Konferenz wird unter https://events.q4inc.com/attendee/455235752 verfügbar sein, und eine Wiederholung wird später unter investor.natera.com zugänglich sein.
- None.
- None.
Earnings Conference Call Information:
Event: |
Natera’s Second Quarter 2024 Financial Results |
Date: |
Thursday, Aug. 8, 2024 |
Time: |
1:30 p.m. PT (4:30 p.m. ET) |
Live Dial-In:
|
1-888-596-4144 (Domestic)
|
Conference ID: |
7684785 |
Webcast: |
A webcast replay will be available at investor.natera.com.
About Natera
Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health, and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 200 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240731467236/en/
Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, investor@natera.com
Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com
Source: Natera, Inc.
FAQ
When will Natera (NTRA) report its Q2 2024 earnings?
What time is Natera's (NTRA) Q2 2024 earnings call?
How can I access Natera's (NTRA) Q2 2024 earnings call?
Where can I find the replay of Natera's (NTRA) Q2 2024 earnings call?
